Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer: Erratum

Remission of psoriasis and psoriatic arthritis during bevacizumab therapy for renal cell cancer: Erratum

Bibliographic Details
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Series:	Indian Journal of Dermatology
Online Access:	http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=2;spage=209;epage=209;aulast=

Similar Items

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Methotrexate in psoriasis and psoriatic arthritis
by: Coates, L, et al.
Published: (2020)

Remission in psoriatic arthritis—where are we now?
by: Coates, L, et al.
Published: (2017)

Considerations for the definition of remission criteria in psoriatic arthritis
by: Mease, P, et al.
Published: (2017)

Treatment of psoriasis and psoriatic arthritis during pregnancy and breastfeeding
by: Patricia Shu Kurizky, et al.
Published: (2015-06-01)

Identification of psoriatic arthritis in patients with psoriasis
by: Coates, LC, et al.
Published: (2023)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: S. V. Smirnova, et al.
Published: (2014-08-01)

Psoriasis and psoriatic arthritis: Topical issues
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

CYCLOSPORIN A (SANDIMMUN NEORAL) IN THERAPY FOR PSORIASIS AND PSORIATIC ARTHRITIS
by: Yulia Leonodovna Korsakova
Published: (2010-09-01)

ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
by: Tatyana G. Sidorcika, et al.
Published: (2018-04-01)

COMORBIDITIES IN PSORIATIC ARTHRITIS AND PSORIASIS: CONSIDERATIONS FOR THE CLINICIAN
by: Lucia Dutca, et al.
Published: (2023-12-01)

Search for predictors of psoriatic arthritis in patients with psoriasis
by: Olga G. Artamonova, et al.
Published: (2023-12-01)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
by: Fernando Valenzuela, et al.
Published: (2021-10-01)

GENETIC FACTORS IN IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: M. V. Smolnikova, et al.
Published: (2014-08-01)

New opportunities in the treatment of psoriasis and psoriatic arthritis
by: A. A. Kubanov, et al.
Published: (2019-01-01)

Use of methotrexate in the treatment of psoriasis and psoriatic arthritis
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-06-01)

Cell and tissue specific functional genomics of psoriasis and psoriatic arthritis
by: Lledo Lara, A
Published: (2019)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
by: Coates, L, et al.
Published: (2016)

Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage
by: Laure Gossec, et al.
Published: (2024-04-01)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
by: Coates, LC, et al.
Published: (2022)

Secukinumab in the therapy of psoriasis and psoriatic arthritis: a safe choice in clinical practice
by: Andrea Chiricozzi
Published: (2018-12-01)

Early endothelial progenitor cells and vascular stiffness in psoriasis and psoriatic arthritis
by: D. Patschan, et al.
Published: (2018-11-01)

The role of HLA-Cw6 in psoriasis and psoriatic arthritis
by: Witold Owczarek
Published: (2022-11-01)

Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis
by: Irmina Olejniczak-Staruch, et al.
Published: (2021-04-01)

Phosphodiesterase-4 inhibitor in the treatment of psoriasis and psoriatic arthritis
by: O. Yu. Olisova, et al.
Published: (2019-07-01)

Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
by: Gisondi P, et al.
Published: (2022-08-01)

Search for genetic markers of predisposition to psoriasis and psoriatic arthritis
by: M. V. Smolnikova, et al.
Published: (2020-12-01)

Can the development of psoriatic arthritis be prevented in patients with psoriasis?
by: E. L. Nasonov, et al.
Published: (2019-07-01)

Sustained very low disease activity and remission in psoriatic arthritis patients
by: Lubrano, E, et al.
Published: (2019)

Influence of the duration of psoriatic arthritis on the achievement of remission and minimal disease activity during therapy with genetically engineered biologic drugs. Data from the all-russian register of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2021-01-01)

Pustular psoriasis triggered by therapy with atezolizumab and bevacizumab
by: Mariani Magnus da Luz Andrade, et al.
Published: (2024-01-01)

The role of epigenetics and immunological imbalance in the etiopathogenesis of psoriasis and psoriatic arthritis
by: Frischknecht, L, et al.
Published: (2019)

Predictive factors of psoriatic arthritis in a diverse population with psoriasis
by: Wai Yang Loo, et al.
Published: (2024-01-01)

Nail Ultrasound in Psoriasis and Psoriatic Arthritis—A Narrative Review
by: Mihaela Agache, et al.
Published: (2023-06-01)

The Frequency of Association of Nail Involvement and Psoriatic Arthritis in Psoriasis Patients
by: Erdal Pala, et al.
Published: (2023-06-01)

Psoriatic Arthritis in Psoriasis Patients: Evaluation of Clinical and Radiological Features
by: Hatice Reşorlu, et al.
Published: (2016-08-01)

LIVER DAMAGE IN PSORIASIS AND PSORIATIC ARTHRITIS: A LITERATURE REVIEW
by: Yu. L. Korsakova, et al.
Published: (2017-09-01)

Ustekinumab is a new drug to treat psoriasis and psoriatic arthritis
by: Yuliya Leonidovna Korsakova, et al.
Published: (2013-04-01)

Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis
by: Yu. L. Korsakova, et al.
Published: (2018-07-01)

A case of vitiligo regression in a patient with psoriasis and psoriatic arthritis receiving adalimumab therapy
by: N. S. Rudneva, et al.
Published: (2021-12-01)